Erez Raphael - 10 Oct 2021 Form 4 Insider Report for DarioHealth Corp. (DRIO)

Role: Chief Executive Officer, Director
Signature: /s/ Erez Raphael
Issuer symbol: DRIO
Transactions as of: 10 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 12 Oct 2021, 16:46:20 UTC
Previous filing: 20 Jul 2021
Next filing: 03 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DRIO	Common Stock	Award	$0	+695	+0.07%	$0.000000	944,682	10 Oct 2021	Direct	F1
holding	DRIO	Common Stock						37,876	10 Oct 2021	By Dicilyon Consulting and Investment Ltd.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021.
F2	The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Content

The reporting person was awarded such securities in exchange for waiving compensation owed for the fourth quarter of 2021.

The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.